These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38681733)

  • 21. Analysis of the CYP2C19 genetic polymorphism in Han and Uyghur patients with cardiovascular and cerebrovascular diseases in the Kashi area of Xinjiang.
    Li Y; Yang H; Zou X; Xiong L; Li Z; Luo J; Zhao B; Liu W; Du X
    Med Sci Monit; 2014 Nov; 20():2213-8. PubMed ID: 25381554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genetic polymorphism, linkage disequilibrium, haplotype structure and novel allele analysis of CYP2C19 and CYP2D6 in Han Chinese.
    Zhou Q; Yu XM; Lin HB; Wang L; Yun QZ; Hu SN; Wang DM
    Pharmacogenomics J; 2009 Dec; 9(6):380-94. PubMed ID: 19636337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Screening different HPV genotypes infection and type-specific in cervical exfoliated cells of women in Yili area of Xinjiang Uygur Autonomous Region, China].
    Pan ZZ; Song YN; Zhang Q; Yu JJ; Zhang KN; Liang N; Zhang N; Ma X; Zhu JL; Zhe XY; Xia HDT; Zheng WN; Li HT; Cao DD; Pan ZM
    Zhonghua Yu Fang Yi Xue Za Zhi; 2018 Sep; 52(9):946-950. PubMed ID: 30196644
    [No Abstract]   [Full Text] [Related]  

  • 24. [Prevalence of
    Cao HF; Dong Y; Yang T; Li BB; Zhao J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2018 Nov; 53(11):730-735. PubMed ID: 30419652
    [No Abstract]   [Full Text] [Related]  

  • 25. Genetic polymorphisms of drug-metabolizing phase I enzymes CYP3A4, CYP2C9, CYP2C19 and CYP2D6 in Han, Uighur, Hui and Mongolian Chinese populations.
    Zuo J; Xia D; Jia L; Guo T
    Pharmazie; 2012 Jul; 67(7):639-44. PubMed ID: 22888523
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Analysis of genetic variations in CYP2C9, CYP2C19, CYP2D6 and CYP3A5 genes using oligonucleotide microarray.
    Dong Y; Xiao H; Wang Q; Zhang C; Liu X; Yao N; Sheng H; Li H
    Int J Clin Exp Med; 2015; 8(10):18917-26. PubMed ID: 26770516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Retrospective Study to Determine Diagnostic Utility of 6 Commonly Used Lung Cancer Biomarkers Among Han and Uygur Population in Xinjiang Uygur Autonomous Region of People's Republic of China.
    Yang-Chun F; Min F; Di Z; Yan-Chun H
    Medicine (Baltimore); 2016 May; 95(18):e3568. PubMed ID: 27149479
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes.
    Singh MS; Francis PA; Michael M
    Breast; 2011 Apr; 20(2):111-8. PubMed ID: 21185724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of tamoxifen based on cytochrome P450 2D6, CYP2C19 and SULT1A1 genotype in the Italian Tamoxifen Prevention Trial.
    Serrano D; Lazzeroni M; Zambon CF; Macis D; Maisonneuve P; Johansson H; Guerrieri-Gonzaga A; Plebani M; Basso D; Gjerde J; Mellgren G; Rotmensz N; Decensi A; Bonanni B
    Pharmacogenomics J; 2011 Apr; 11(2):100-7. PubMed ID: 20309015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CYP2C9, CYP2C19, CYP2D6 and CYP3A5 polymorphisms in South-East and East Asian populations: A systematic review.
    Dorji PW; Tshering G; Na-Bangchang K
    J Clin Pharm Ther; 2019 Aug; 44(4):508-524. PubMed ID: 30980418
    [TBL] [Abstract][Full Text] [Related]  

  • 31. CYP2C9, CYP2C19 and CYP2D6 allele frequencies in the Ashkenazi Jewish population.
    Scott SA; Edelmann L; Kornreich R; Erazo M; Desnick RJ
    Pharmacogenomics; 2007 Jul; 8(7):721-30. PubMed ID: 18240905
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Multigene and Drug Interaction Approach for Tamoxifen Metabolite Patterns Reveals Possible Involvement of CYP2C9, CYP2C19, and ABCB1.
    Powers JL; Buys SS; Fletcher D; Melis R; Johnson-Davis KL; Lyon E; Malmberg EM; McMillin GA
    J Clin Pharmacol; 2016 Dec; 56(12):1570-1581. PubMed ID: 27198207
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy.
    Mwinyi J; Vokinger K; Jetter A; Breitenstein U; Hiller C; Kullak-Ublick GA; Trojan A
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1181-8. PubMed ID: 24682508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ethnic disparities in the clustering of risk factors for cardiovascular disease among the Kazakh, Uygur, Mongolian and Han populations of Xinjiang: a cross-sectional study.
    Li N; Wang H; Yan Z; Yao X; Hong J; Zhou L
    BMC Public Health; 2012 Jul; 12():499. PubMed ID: 22759741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Study on the relationship between SNP of CD14 gene and allergic rhinitis in Xinjiang Uygurs and Hans].
    Zhang H; Hu H; Liu Z; Sun J; Yang Y; Wang Y; Tan G; Xiang Y
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2011 Dec; 25(23):1076-80. PubMed ID: 22384567
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CYP2D6 genotype and tamoxifen response in postmenopausal women with endocrine-responsive breast cancer: the breast international group 1-98 trial.
    Regan MM; Leyland-Jones B; Bouzyk M; Pagani O; Tang W; Kammler R; Dell'orto P; Biasi MO; Thürlimann B; Lyng MB; Ditzel HJ; Neven P; Debled M; Maibach R; Price KN; Gelber RD; Coates AS; Goldhirsch A; Rae JM; Viale G;
    J Natl Cancer Inst; 2012 Mar; 104(6):441-51. PubMed ID: 22395644
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genetic polymorphisms in MDR1 and CYP3A5 and MDR1 haplotype in mainland Chinese Han, Uygur and Kazakh ethnic groups.
    Li D; Zhang GL; Lou YQ; Li Q; Wang X; Bu XY
    J Clin Pharm Ther; 2007 Feb; 32(1):89-95. PubMed ID: 17286792
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Correlation between
    Abulizi P; Zhou XH; Keyimu K; Luo M; Jin FQ
    Oncotarget; 2017 Sep; 8(43):75174-75185. PubMed ID: 29088855
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An analysis of allele, genotype and phenotype frequencies, actionable pharmacogenomic (PGx) variants and phenoconversion in 5408 Australian patients genotyped for CYP2D6, CYP2C19, CYP2C9 and VKORC1 genes.
    Mostafa S; Kirkpatrick CMJ; Byron K; Sheffield L
    J Neural Transm (Vienna); 2019 Jan; 126(1):5-18. PubMed ID: 30191366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Relationship between thyrotropin and urine iodine in Han and Uygur nationalities pregnancy women in People's Hospital of Xinjiang Uygur Autonomous Region].
    Renaguli A; Luo YZ; Wang XL; Dilidaer Y; Muyeshsaer W; Guzailinuer J; Zhang YY; Xin YY; Guo Y
    Zhonghua Fu Chan Ke Za Zhi; 2018 Sep; 53(9):595-601. PubMed ID: 30293294
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.